| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817743 | Clinical Biochemistry | 2015 | 32 Pages |
Abstract
We concluded that uPAR/suPAR is elevated in most kidney diseases and that suPAR is a useful biomarker for assessing stages of DN.
Keywords
NCRTESRDIDMS3-amino-9-ethylcarbazoleAECFSGSCKD-EPIMCDEGFRIgANimmunohistochemicalIHCminimal change diseasechronic kidney diseaseanalysis of varianceANOVAEnzyme-linked immunosorbent assayELISACinDiabetes mellitusHourIsotope dilution mass spectrometryend stage renal diseaseestimated glomerular filtration rateCKDDiabetic nephropathyLupus nephropathyChronic Kidney Disease Epidemiology CollaborationFocal segmental glomerulosclerosis
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Chung-Ze Wu, Li-Chien Chang, Yuh-Feng Lin, Yi-Jen Hung, Dee Pei, Nain-Feng Chu, Jin-Shuen Chen,